169 related articles for article (PubMed ID: 25144649)
21. TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.
Zhu C; Di D; Zhang X; Luo G; Wang Z; Wei J; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2011 Nov; 10():199. PubMed ID: 22054074
[TBL] [Abstract][Full Text] [Related]
22. Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication.
Gu JG; Zhu CL; Cheng DZ; Xie Y; Liu F; Zhou X
Lipids Health Dis; 2011 Aug; 10():154. PubMed ID: 21875437
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.
Elsøe S; Christoffersen C; Luchoomun J; Turner S; Nielsen LB
Biochim Biophys Acta; 2013 Jul; 1831(7):1287-92. PubMed ID: 24046869
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
[TBL] [Abstract][Full Text] [Related]
25. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M; Okada H; Dahlbäck B
Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
[TBL] [Abstract][Full Text] [Related]
26. [The expression of insulin signal transduction molecules and islet alpha cell insulin resistance].
Du RQ; Li HL; Yang WY; Xiao JZ; Lou DJ; Wang B; Bai XP; Pan L
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2542-6. PubMed ID: 17198562
[TBL] [Abstract][Full Text] [Related]
27. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.
Christoffersen C; Ahnström J; Axler O; Christensen EI; Dahlbäck B; Nielsen LB
J Biol Chem; 2008 Jul; 283(27):18765-72. PubMed ID: 18460466
[TBL] [Abstract][Full Text] [Related]
28. Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo.
Xu N; Nilsson-Ehle P; Hurtig M; Ahrén B
Biochem Biophys Res Commun; 2004 Sep; 321(4):916-21. PubMed ID: 15358114
[TBL] [Abstract][Full Text] [Related]
29. Insulin Resistance in Apolipoprotein M Knockout Mice is Mediated by the Protein Kinase Akt Signaling Pathway.
Yao S; Zhang J; Zhan Y; Shi Y; Yu Y; Zheng L; Xu N; Luo G
Endocr Metab Immune Disord Drug Targets; 2020; 20(5):771-780. PubMed ID: 31702495
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein M regulates the orphan nuclear receptor LRH-1 gene expression through binding to its promoter region in HepG2 cells.
Pan Y; Zhou HG; Zhou H; Hu M; Tang LJ
Drug Des Devel Ther; 2015; 9():2375-82. PubMed ID: 25987835
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo.
Pereira S; Park E; Moore J; Faubert B; Breen DM; Oprescu AI; Nahle A; Kwan D; Giacca A; Tsiani E
Appl Physiol Nutr Metab; 2015 Nov; 40(11):1129-36. PubMed ID: 26455923
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.
Mulya A; Seo J; Brown AL; Gebre AK; Boudyguina E; Shelness GS; Parks JS
J Lipid Res; 2010 Mar; 51(3):514-24. PubMed ID: 19767535
[TBL] [Abstract][Full Text] [Related]
33. HDL stimulates apoM secretion.
Ahnström J; Axler O; Dahlbäck B
Protein Pept Lett; 2010 Oct; 17(10):1285-9. PubMed ID: 20518736
[TBL] [Abstract][Full Text] [Related]
34. Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXRα expression in HepG2 cells.
Zhao JY; Hu YW; Li SF; Hu YR; Ma X; Wu SG; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
Lipids Health Dis; 2014 Mar; 13():50. PubMed ID: 24642298
[TBL] [Abstract][Full Text] [Related]
35. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
[TBL] [Abstract][Full Text] [Related]
36. Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA.
Lee FN; Zhang L; Zheng D; Choi WS; Youn JH
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E69-74. PubMed ID: 15026305
[TBL] [Abstract][Full Text] [Related]
37. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.
Christoffersen C; Benn M; Christensen PM; Gordts PLSM; Roebroek AJM; Frikke-Schmidt R; Tybjaerg-Hansen A; Dahlbäck B; Nielsen LB
J Lipid Res; 2012 Oct; 53(10):2198-2204. PubMed ID: 22826357
[TBL] [Abstract][Full Text] [Related]
38. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
[TBL] [Abstract][Full Text] [Related]
39. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
Koopmans SJ; Kushwaha RS; DeFronzo RA
Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
[TBL] [Abstract][Full Text] [Related]
40. Increased mRNA levels of apolipoprotein M and apolipoprotein AI in the placental tissues with fetal macrosomia.
Yu Y; Luo GH; Zhang J; Jiang H; Wei J; Shi YP; Zhang XY; Xu N
Arch Gynecol Obstet; 2015 Feb; 291(2):299-303. PubMed ID: 25194312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
